ROIV - Immunovant climbs on Phase 1 data for autoimmune drug
2023-09-26 06:59:12 ET
More on Immunovant
- Seeking Alpha’s Quant Rating on Immunovant
- Historical earnings data for Immunovant
- Financial information for Immunovant
- Immunovant Stock: With Anti-FcRn Validation Continuing, This Is A Must-Watch
- Immunovant stock jumps on positive data for Argenx drug (update)
For further details see:
Immunovant climbs on Phase 1 data for autoimmune drug